Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property.
Market based solutions to bring down the cost of drug prices. Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Issuing new codes in a timely fashion for the Medicare End-Stage Renal Disease (ESRD) Program.
Duration: March 4, 2015
to
present
May Have Ended?
General Issues: Taxation/Internal Revenue Code , Health Issues , Medicare/Medicaid
Spending: about $300,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: U.S. Senate, House of Representatives, Natl Economic Council (NEC), Treasury - Dept of, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Matt McGinley
Chief of Staff, Rep. Tom Price (2004-11)
Chief of Staff, Republican Policy Committee (2010-11)
DCOS & LD, Rep. Brian Kerns (2002-03)
Chief of Staff, Rep. Tom Price (2004-11); Chief of Staff, Republican Policy Committee (2010-11); DCOS & LD, Rep. Brian Kerns (2002-03)
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
This representation may have ended. No reports have been filed in the past 160 days, though termination paperwork has not been released.
3rd Quarter, 2017
In Q3, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $50,000. The report was filed on Oct. 9, 2017.
Original Filing: 300902088.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Economic Council (NEC) Treasury - Dept of
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Market based solutions to bring down the cost of drug prices. Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Issuing new codes in a timely fashion for the Medicare End-Stage Renal Disease (ESRD) Program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
2nd Quarter, 2017
In Q2, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $50,000. The report was filed on July 17, 2017.
Original Filing: 300885823.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Economic Council (NEC) Treasury - Dept of
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Market based solutions to bring down the cost of drug prices. Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Issuing new codes in a timely fashion for the Medicare End-Stage Renal Disease (ESRD) Program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
1st Quarter, 2017
In Q1, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $50,000. The report was filed on April 17, 2017.
Original Filing: 300866689.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Advocating for market based solutions to bring done the cost of drug prices. Issues related to Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products, which would put patient access and quality of care at risk.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
4th Quarter, 2016
In Q4, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $20,000. The report was filed on Dec. 29, 2016.
Original Filing: 300843224.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. The international tax code as it relates to the treatment of U.S. companies doing business in Puerto Rico. H.R. 4900, the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA), as it relates to the tax treatment of U.S. companies doing business in Puerto Rico.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Opposition to the Center for Medicare and Medicaid Innovation's (CMMI) new Part B Drug model, which would put patient access and quality of care at risk.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $20,000. The report was filed on Oct. 13, 2016.
Original Filing: 300827440.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. The international tax code as it relates to the treatment of U.S. companies doing business in Puerto Rico. H.R. 4900, the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA), as it relates to the tax treatment of U.S. companies doing business in Puerto Rico.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Opposition to the Center for Medicare and Medicaid Innovation's (CMMI) new Part B Drug model, which would put patient access and quality of care at risk.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $20,000. The report was filed on July 15, 2016.
Original Filing: 300810263.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. The international tax code as it relates to the treatment of U.S. companies doing business in Puerto Rico. H.R. 4900, the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA), as it relates to the tax treatment of U.S. companies doing business in Puerto Rico.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $20,000. The report was filed on April 17, 2016.
Original Filing: 300792605.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. The international tax code as it relates to the treatment of U.S. companies doing business in Puerto Rico. H.R. 4900, the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA), as it relates to the tax treatment of U.S. companies doing business in Puerto Rico.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $20,000. The report was filed on Jan. 15, 2016.
Original Filing: 300773473.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property; international tax code as it relates to the treatment of U.S. companies doing business in Puerto Rico; and research and development (R&D) tax credit; tax extender legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $20,000. The report was filed on Oct. 15, 2015.
Original Filing: 300753566.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property; international tax code as it relates to the treatment of U.S. companies doing business in Puerto Rico and tax extender legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2015
In Q2, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $20,000. The report was filed on July 20, 2015.
Original Filing: 300743285.xml
Lobbying Issues
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2015
In Q1, Advanced Policy Consulting, LLC lobbied for Amgen USA Inc. , earning $10,000. The report was filed on April 20, 2015.
Original Filing: 300726124.xml
Lobbying Issues
Tax Reform: International tax provisions. Budget Resolution - H. Con. Res. 27.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate